Literature DB >> 30495991

Evidence-Based Pain Management: Building on the Foundations of Cochrane Systematic Reviews.

Dominic Aldington1, Chris Eccleston1.   

Abstract

We discuss the history and current status of evidence-based medicine for the prevention and treatment of acute and chronic pain as it has developed in the Cochrane Collaboration's Pain, Palliative and Supportive Care Review Group.To date, the Pain, Palliative and Supportive Care Review Group has published 277 reviews and a further 11 reviews of systematic reviews summarizing the evidence for interventions. The Cochrane Library has readily available high-quality summaries of evidence of pharmacological interventions especially for postsurgical pain but also for chronic musculoskeletal and neuropathic pain. The library covers all forms of intervention, not only pharmacological.The world of evidence-based medicine is changing: most historical trials have been entered into reviews, but the evidence is still not well disseminated and needs to be better translated into decision support. Evidence should be at the heart of policymaking. Much has been achieved in the past 21 years, but there are no grounds for complacency.

Entities:  

Mesh:

Year:  2018        PMID: 30495991      PMCID: PMC6301419          DOI: 10.2105/AJPH.2018.304745

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  21 in total

Review 1.  "Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews.

Authors:  Andrew R Moore; Christopher Eccleston; Sheena Derry; Phillip Wiffen; Rae F Bell; Sebastian Straube; Henry McQuay
Journal:  Pain       Date:  2010-06-02       Impact factor: 6.961

Review 2.  Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Jana Hudcova
Journal:  Cochrane Database Syst Rev       Date:  2015-06-02

3.  Expect analgesic failure; pursue analgesic success.

Authors:  Andrew Moore; Sheena Derry; Christopher Eccleston; Eija Kalso
Journal:  BMJ       Date:  2013-05-03

4.  Evidence based medicine manifesto for better healthcare: A response to systematic bias, wastage, error and fraud in research underpinning patient care.

Authors:  Carl Heneghan; Kamal R Mahtani; Ben Goldacre; Fiona Godlee; Helen Macdonald; Duncan Jarvies
Journal:  Evid Based Med       Date:  2017-07-18

Review 5.  Amitriptyline for neuropathic pain in adults.

Authors:  R Andrew Moore; Sheena Derry; Dominic Aldington; Peter Cole; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2015-07-06

6.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

Review 7.  Gabapentin for chronic neuropathic pain in adults.

Authors:  Philip J Wiffen; Sheena Derry; Rae F Bell; Andrew Sc Rice; Thomas Rudolf Tölle; Tudor Phillips; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-06-09

Review 8.  Pharmacotherapy for the prevention of chronic pain after surgery in adults.

Authors:  Luis Enrique Chaparro; Shane A Smith; R Andrew Moore; Philip J Wiffen; Ian Gilron
Journal:  Cochrane Database Syst Rev       Date:  2013-07-24

Review 9.  Cognitive behavioural therapies for fibromyalgia.

Authors:  Kathrin Bernardy; Petra Klose; Angela J Busch; Ernest H S Choy; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2013-09-10

Review 10.  Botulinum toxin for myofascial pain syndromes in adults.

Authors:  Adriana Soares; Régis B Andriolo; Alvaro N Atallah; Edina M K da Silva
Journal:  Cochrane Database Syst Rev       Date:  2014-07-25
View more
  1 in total

1.  Factors That Influence Changes to Existing Chronic Pain Management Plans.

Authors:  Julie Diiulio; Laura G Militello; Barbara T Andraka-Christou; Robert L Cook; Robert W Hurley; Sarah M Downs; Shilo Anders; Burke W Mamlin; Elizabeth C Danielson; Christopher A Harle
Journal:  J Am Board Fam Med       Date:  2020 Jan-Feb       Impact factor: 2.657

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.